Clinical Trials Now Enrolling
Status: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT06072586 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT07268053 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Not Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT06824662 to view inclusion criteria and additional study details.
Trial ScreeningEmavusertib (CA-4948) in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma
Status: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT06883747 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT06388733 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT06883747 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT05940493 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Not Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT04559685 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT03180268 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT04840069 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT05438212 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT02523014 to view inclusion criteria and additional study details.
Trial ScreeningStatus: Recruiting
Visit ClinicalTrials.gov or use NCT identifier NCT05303519 to view inclusion criteria and additional study details.
Trial Screening